Publications Co-authored or Contributed to by Library Staff

Raghavendra AS, Bassett R Jr, Damodaran S, et al. Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal Carcinoma. JAMA Netw Open. 2025 Apr 1;8(4):e251888.

Alsbrook KE, Hagan Thomas T, DeVito Dabbs A, et al. Associations Among Self-Advocacy, Patient-Centered Communication, Pain Intensity, and Opioid Stigma in Older Adult Female Breast Cancer Survivors. Oncol Nurs Forum. 2025 Apr 23;52(3):168-178.

Chen JH, Geng Y, Lucci A. Applications of ctDNA testing to monitor and detect residual disease in breast cancer. Expert Rev Mol Diagn. 2025 Apr 28:1-12.

Windon MJ, Saba NF, Amit M. Ushering in Neoadjuvant Immune Checkpoint Inhibitors for Mucosal Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025 Apr 24.

Zheng G, Wei P, Li D, et al. A Deep Learning Survival Model for Evaluating the Survival Prognosis of Papillary Thyroid Cancer: A Population-Based Cohort Study. Ann Surg Oncol. 2025 Apr 20.

Wilke RN, Wu CF, Kanbergs A, et al. Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2025 Apr 17;197:11-18.

Admane S, Pasyar S, Bassett R Jr, et al. Circadian rhythm in end-of-life delirium: a secondary analysis of two randomized controlled trials. J Pain Symptom Manage. 2025 Apr 14.

Nardo M, Braganca Xavier C, Stephen B, et al. Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial. J Immunother Precis Oncol. 2025 Apr 10;8(2):143-151.

Veletic I, Harris DM, Rozovski U, et al. CLL cell-derived exosomes alter the immune and hematopoietic systems. Leukemia. 2025 Apr 4.

Chien KS, Braish JS, Li Z, et al. Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasms. Leukemia. 2025 Apr 2.

Bhala R, Cando LF, Verma P, et al. Biomarkers Predicting Progression and Prognosis of Ductal Carcinoma In Situ (DCIS). Anticancer Res. 2025 Apr;45(4):1305-1328.

Nielsen A, Martinez A, Dains J. Cancer Patient Perspectives on Medical Aid in Dying: An Integrative Review. Cancer Care Research Online 5(2):p e070, April 2025.

Xu T, Chakraborty S, Wei D et al. Evaluation of the protective effect of Compound Kushen Injection against radiation‑induced lung injury in mice.. Mol Med Rep. 2025 Apr;31(4):88.

Maki H, Ayabe RI, Haddad A, et al. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr;32(4):2425-2434.

Ruiz JI, Radabaugh C, Geng Y, Suarez-Almazor ME. Content and quality of consumer websites providing information about human papillomavirus infection in patients with systemic lupus erythematosus: An environmental scan. Patient Educ Couns. 2025 Apr:133:108644.

Bayraktar EC, Aung PP, Gill P, et al. Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes. J Cutan Pathol. 2025 Apr;52(4):309-316.

Lu C, Martinez A, Dains J. Comparison of Quality of Life in Tongue Cancer Patients Following Various Glossectomy Reconstructive Techniques. J Adv Pract Oncol. 2025 Mar 16:1-9.

Bataller A, Sasaki K, Urrutia S, et al. Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. Blood Cancer J. 2025 Mar 31;15(1):50.

Kuerer HM, Valero V, Smith BD, et al. Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Mar 28:e250207.

Admane S, Bramati PS, Fellman B, et al. Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021. JCO Oncol Pract. 2025 Mar 26:OP2400782.

Admane S, Kim MJ, Reddy A, et al. Performance of Three Conversational Artificial Intelligence Agents in Defining End-of-Life Care Terms. J Palliat Med. 2025 Mar 26.

Minamiguchi K, Maki H, Haddad A, et al. Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy. Eur Radiol. 2025 Mar 24.

Rhee DJ, Perni S, Perrin KJ, et al. Semi-automated hippocampal avoidance whole-brain radiotherapy planning. J Appl Clin Med Phys. 2025 Mar 18;e70076.

Gonzalez XT, Roubaud MS, Schaverien MV, et al. Assessment of Appearance-related Questions About Breast Reconstruction Generated by Chat Generative Pre-trained Transformer. Plast Reconstr Surg Glob Open. 2025 Mar 21;13(3):e6625.

Odisio BC, Albuquerque J, Lin Y-M, et al. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2025 Mar 13:S2468-1253(25)00024-X.

Silva E, Vetter TR. Awake Craniotomy for a Deaf Patient: A Case Report. A A Pract. 2025 Mar 14;19(3):e01936.

Agustí N, Viveros-Carreño D, Wu C-F, et al. Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer. JAMA Oncol. 2025 Mar 13:e250146.

Laserna A, Cuenca JA, Martin P, Fowler C, Barahona-Correa J, Manjappachar N, Fowler C, et al. Mortality time frame variability in septic shock clinical trials: A systematic review. Med Intensiva (Engl Ed). 2025 Mar 15:502172.

Chelariu-Raicu A, Vu TC, Umamaheswaran S, et al. IMGN853 induces autophagic cell death in combination therapy for ovarian cancer. Cancer Res Commun. 2025 Mar 3.

Mishra A, San Valentin EMD, Barcena AJR, et al. Antibody-Targeted Bismuth Gadolinium Nanoconjugate for Image-Guided Radiotherapy of Hepatocellular Carcinoma. ACS Appl Mater Interfaces. 2025 Mar 3.

Shafat T, De-la-Rosa-Martinez D, Khawaja F, et al. Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients with Lymphoma or Multiple Myeloma – A 7-year Retrospective Cohort Study. Open Forum Infectious Diseases. 2025 Mar 4.

Gouda MA, Ballesteros PA, Garrido-Laguna I, Rodon J. Efficacy assessment in phase I clinical trials: endpoints and challenges. Ann Oncol. 2025 Mar 4:S0923-7534(25)00081-X.

Thomas K, Trinh H, Fei A, et al. Cytologic features of angiosarcoma in fluid specimens: A retrospective study of 22 cases. Cancer Cytopathol. 2025 Mar;133(3):e70004.

George M, Mustafayev K, Ahmed S, et al. Direct-Acting Antivirals Induce Lymphoproliferative Disease Response in HCV-Infected Patients With Indolent B-Cell Non-Hodgkin's Lymphoma: A Prospective Observational Study. Hematol Oncol. 2025 Mar;43(2):e70044.